Cohance Lifesciences

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue563.48571.17550.71617.28434.51
Expenses492.62487.40505.25580.86477.38
EBITDA126.18136.55101.5196.8413.41
Operating Profit72.9492.5349.7129.10-36.13
Profit Before Tax62.7683.7740.6019.91-42.87
Net Profit46.4066.3929.028.31-45.19
Financial Ratios
Operating Profit Margin21.50%24.58%17.75%12.97%3.18%
Net Profit Margin9.95%13.33%7.36%2.85%-5.71%
Earning Per Share (Diluted)1.271.930.960.50-0.65
Dividends Per Share0.000.000.000.000.00